Polaryx Therapeutics Inc (PLYX)

Finanzdaten der Polaryx Therapeutics Inc-Aktie (PLYX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
	29.52%1.38	1.96
Research and Development	5.89%0.72	0.68
Operating Income/Loss	29.52%-1.38	-1.96
	45.75%-1.38	-2.54
Attributable To Parent	45.75%-1.38	-2.54
Available To Common Stockholders, Basic	45.75%-1.38	-2.54
Basic Average Shares	2.24%48.28	47.22
Diluted Average Shares	2.24%48.28	47.22
Basic Earnings Per Share	40.00%-0.03	-0.05
Diluted Earnings Per Share	40.00%-0.03	-0.05